Related references
Note: Only part of the references are listed.Integrated Application of Quality-by-Design Principles to Drug Product Development: A Case Study of Brivanib Alaninate Film-Coated Tablets
Sherif I. F. Badawy et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Orodispersible drug formulations for children and elderly
Marta Slavkova et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Influence of the preparation method on the physicochemical properties of indomethacin and methyl-β-cyclodextrin complexes
Shashi Ravi Suman Rudrangi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Characterising the disintegration properties of tablets in opaque media using texture analysis
Rebekah L. Scheuerle et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Validation and applications of an expedited tablet friability method
Frederick Osei-Yeboah et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Studies on the complexation of diclofenac sodium with β-cyclodextrin: Influence of method of preparation
Subhraseema Das et al.
JOURNAL OF MOLECULAR STRUCTURE (2015)
Understanding Pharmaceutical Quality by Design
Lawrence X. Yu et al.
AAPS JOURNAL (2014)
Functionality of Disintegrants and Their Mixtures in Enabling Fast Disintegration of Tablets by a Quality by Design Approach
Parind Mahendrakumar Desai et al.
AAPS PHARMSCITECH (2014)
Development of nanocrystal formulation of meloxicam with improved dissolution and pharmacokinetic behaviors
Masanori Ochi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
Impact of active ingredients on the swelling properties of orally disintegrating tablets prepared by microwave treatment
Syusuke Sano et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
OPTIMIZATION AND ACESSING THE INFLUENCE OF XANTHAN GUM, EFFERVESCENT COMPONENTS AND HARDNESS ON FLOATATION BEHAVIOR AND DRUG RELEASE OF GASTROFLOATING CAPTOPRIL TABLET
Syaiful Choiri et al.
INDONESIAN JOURNAL OF PHARMACY (2014)
The Bad Taste of Medicines: Overview of Basic Research on Bitter Taste
Julie A. Mennella et al.
CLINICAL THERAPEUTICS (2013)
Orally disintegrating tablet of novel salt of antiepileptic drug: Formulation strategy and evaluation
Ziyaur Rahman et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2013)
Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets
Yoshinori Nakano et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Intra-articular injection of the selective cyclooxygenase-2 inhibitor meloxicam (Mobic) reduces experimental osteoarthritis and nociception in rats
Z. -H. Wen et al.
OSTEOARTHRITIS AND CARTILAGE (2013)
Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets
Ritesh M. Pabari et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2012)
Preparation of meloxicam-β-cyclodextrin-polyethylene glycol 6000 ternary system: characterization, in vitro and in vivo bioavailability
Ourezki Radia et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2012)
Analysis of co-spray-dried meloxicam-mannitol systems containing crystalline microcomposites
Anita Pomazi et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
Development and evaluation of mathematical model to predict disintegration time of fast disintegrating tablets using powder characteristics
H. Goel et al.
PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY (2011)
Risperidone solid dispersion for orally disintegrating tablet: Its formulation design and non-destructive methods of evaluation
Ziyaur Rahman et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam
R. Ambrus et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)
The effect of β-cyclodextrin on the solubility and dissolution rate of meloxicam and investigation of the driving force for complexation using molecular modeling
Aiman A. Obaidat et al.
JOURNAL OF INCLUSION PHENOMENA AND MACROCYCLIC CHEMISTRY (2009)
Physical characterization of meloxicam-β-cyclodextrin inclusion complex pellets prepared by a fluid-bed coating method
Yi Lu et al.
PARTICUOLOGY (2009)
Cycloxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
Y-F Chen et al.
HEALTH TECHNOLOGY ASSESSMENT (2008)
Formulation and evaluation of rapidly disintegrating fenoverine tablets: Effect of superdisintegrants
Sunil Kumar Battu et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2007)
Cyclodextrins as pharmaccutical solubilizers
Marcus E. Brewster et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Cyclodextrins and their pharmaceutical applications
Thorsteinn Loftsson et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Improved absorption of meloxicam via salt formation with ethanolamines
Hyo-Kyung Han et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Enhancement of the dissolution and permeation rates of meloxicam by formation of its freeze-dried solid dispersions in polyvinylpyrrolidone K-30
M El-Badry et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2006)
Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems
NB Naidu et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2004)
Evolution of the interaction of a new chemical entity, eflucimibe, with γ-cyclodextrin during kneading process
A Gil et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Share Paper
